
According to the UK Official Charts released on the 19th, "Who," the title track of Jimin's second solo album MUSE ranked No. 13 on the Singles Chart Top 100.
With this, "Who" extends its record of 20 weeks as the longest-charting song by a Korean solo artist since chart reformat in 2014. It is the fourth longest-charting song among all K-pop songs, following Psy's "Gangnam Style," BTS' "Dynamite," and Fifty Fifty's "Cupid."
After its release on July 19 last year, "Who" debuted at No. 4 on the Singles Top 100 and continued to chart for 17 consecutive weeks. It re-entered at No. 64 on January 9, and climbed a whopping 59 spots to No. 5 on January 16. It remains in the upper ranks at No. 13 in the latest chart. The UK Official Charts is considered as one of the world's two biggest music charts along with the US Billboard chart.
“Who” by Jimin debuts at #4 on the UK Official Singles Chart! 🇬🇧
— Jimin Global | MUSE (@JiminGlobal) July 26, 2024
It is the highest new entry this week.
This also marks Jimin’s highest debut on the chart! 🔥
Congratulations, Jimin! 👏🏼#Who_4_UKSinglesChart #Who_UKDebut #Jimin_Who
pic.twitter.com/u8fjumvwMN
"Who" on UK Official Charts 🇬🇧
— Jimin Global | MUSE (@JiminGlobal) January 17, 2025
• Singles Chart — #13 (20 weeks)
• Singles Downloads — #14 (RE) (19 weeks)
• Singles Sales — #17 (RE) (19 weeks)
• Audio Streaming — #20 (25 weeks)
• Streaming Chart — #22 (25 weeks)
pic.twitter.com/RFvFooVj6J
"WHO" by #JIMIN is now the FIRST song by a K-Act to remain at #1 for a third week on both UK Official Singles Downloads & Sales Chart !
— Jimin Global | MUSE (@JiminGlobal) August 9, 2024
Congratulations Jimin 👏🏼 🥳 pic.twitter.com/USqf0EyDpe
"Who" sets a new record as the longest-charting song by a Korean or K-pop male solo artist on Spotify UK in history — 130 days! 🇬🇧
— Jimin Global | MUSE (@JiminGlobal) January 2, 2025
Congratulations, Jimin! 👏#Jimin_Who
HISTORY MAKER JIMIN pic.twitter.com/g8E7rhXMgG
No comments:
Post a Comment